Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to Pembrolizumab in a Patient with Relapsing Thymoma.

× No keyword cloud information.

13 in total

Review 1. Thymic tumors and immune checkpoint inhibitors.

Authors: Shintaro Yokoyama; Hiroaki Miyoshi
Journal: J Thorac Dis Date: 2018-05 Impact factor: 2.895

2. Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.

Authors: Dwight Owen; Benjamin Chu; Amy M Lehman; Lakshmanan Annamalai; Jennifer H Yearley; Konstantin Shilo; Gregory A Otterson
Journal: J Thorac Oncol Date: 2018-04-24 Impact factor: 15.609

Review 3. Novel Agents in the Treatment of Thymic Malignancies.

Authors: Claire Merveilleux du Vignaux; Jean-Michel Maury; Nicolas Girard
Journal: Curr Treat Options Oncol Date: 2017-08-10

Review 4. Immune checkpoints in thymic epithelial tumors: challenges and opportunities.

Authors: Nicolas Girard
Journal: Immunooncol Technol Date: 2019-09-16

5. A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy.

Authors: Alice Horisberger; Stefano La Rosa; Jean-Philippe Zurcher; Stefan Zimmermann; Francois Spertini; George Coukos; Michel Obeid
Journal: J Immunother Cancer Date: 2018-12-27 Impact factor: 13.751

6. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms.

Authors: Rumi Higuchi; Taichiro Goto; Yosuke Hirotsu; Takahiro Nakagomi; Yujiro Yokoyama; Sotaro Otake; Kenji Amemiya; Toshio Oyama; Masao Omata
Journal: J Clin Med Date: 2019-11-01 Impact factor: 4.241

7. Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report.

Authors: Li Shen; Haiyan Chen; Qichun Wei
Journal: Front Immunol Date: 2021-04-15 Impact factor: 7.561

8. Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report.

Authors: Jonathan Wong-Chong; Maureen Bernadach; Angeline Ginzac; Hugo Veyssière; Xavier Durando
Journal: World J Clin Cases Date: 2021-02-16 Impact factor: 1.337

Review 9. Checkpoint Inhibitors and the Gut.

Authors: Tuan Tran; Nguyen Giang Tien Tran; Vincent Ho
Journal: J Clin Med Date: 2022-02-04 Impact factor: 4.241

10. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.

Authors: Fanny Zulay Acero Brand; Nicolas Suter; Jean-Philippe Adam; Bernard Faulques; Antonio Maietta; Denis Soulières; Normand Blais
Journal: J Immunother Cancer Date: 2018-03-16 Impact factor: 13.751